title: Electrophysiological study in neuromuscular junction disorders.
abstract: This review is on ultrastructure and subcellular physiology at normal and abnormal neuromuscular junctions. The clinical and electrophysiological findings in myasthenia gravis, Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes, and botulinum intoxication are discussed. Single fiber electromyography (SFEMG) helps to explain the basis of testing neuromuscular junction function by repetitive nerve stimulation (RNS). SFEMG requires skill and patience and its availability is limited to a few centers. For RNS supramaximal stimulation is essential and so is display of the whole waveform of each muscle response at maximum amplitude. The amplitudes of the negative phase of the first and fourth responses are measured from baseline to negative peak, and the percent change of the fourth response compared with the first represents the decrement or increment. A decrement greater than 10% is accepted as abnormal and smooth progression of response amplitude train and reproducibility form the crux. In suspected LEMS the effect of fast rates of stimulation should be determined after RNS response to slow rates of stimulation. Caution is required to avoid misinterpretation of potentiation and pseudofacilitation.
authors: Department of Neurology, Government Medical College, Trivandrum, Kerala, India.
authors: Ajith
authors: A
authors: Cherian
authors: Neeraj N
authors: NN
authors: Baheti
authors: Thomas
authors: T
authors: Iype
keywords: Acetylcholine; Lambert–Eaton myasthenic syndrome; congenital myasthenic syndromes; myasthenia gravis; repetitive nerve stimulation; single-fiber electromyography
references: Muscle Nerve. 1996 Sep;19(9):1069-83
references: 8761262
references: J Neurol Neurosurg Psychiatry. 1980 Nov;43(11):978-85
references: 6255102
references: Am J Physiol. 1975 Dec;229(6):1632-4
references: 1211496
references: Neurology. 1987 Aug;37(8):1383-5
references: 3614664
references: Arch Ophthalmol. 1967 Feb;77(2):157-60
references: 6019006
references: Mol Neurobiol. 2002 Oct-Dec;26(2-3):347-67
references: 12428764
references: Lancet. 2009 Jan 31;373(9661):432
references: 19186275
references: Muscle Nerve. 1984 Mar-Apr;7(3):250-7
references: 6323981
references: Muscle Nerve. 2008 Jun;37(6):694-9
references: 18506720
references: Neurology. 2003 May 27;60(10):1710-3
references: 12771277
references: Pract Neurol. 2009 Dec;9(6):364-71
references: 19923120
references: Ann Neurol. 1977 May;1(5):481-5
references: 214021
references: Eur J Neurol. 2006 Jul;13(7):691-9
references: 16834699
references: Arch Neurol. 1981 Aug;38(8):531
references: 7247793
references: J Physiol. 1983 Nov;344:335-45
references: 6655585
references: J Physiol. 1973 Oct;234(2):327-52
references: 4358351
references: Neurology. 1977 Sep;27(9):812-6
references: 561337
references: Expert Rev Clin Immunol. 2006 Mar;2(2):293-307
references: 20477079
references: Neurology. 1973 Sep;23(9):977-80
references: 4353553
references: West J Med. 1985 Jun;142(6):797-809
references: 3895751
references: J Physiol. 1965 Jun;178(3):505-29
references: 5827910
references: J Neuroimmunol. 2008 Sep 15;201-202:2-5
references: 18708269
references: Muscle Nerve. 1992 Feb;15(2):151-61
references: 1312674
references: Neuropharmacology. 2004 Aug;47(2):304-14
references: 15223309
references: Neurology. 1978 Feb;28(2):130-8
references: 202890
references: Ann Neurol. 1984 Nov;16(5):519-34
references: 6095730
references: Muscle Nerve. 1990 Mar;13(3):187-91
references: 2320039
references: Arch Neurol. 1973 Dec;29(6):425-31
references: 4357216
references: Ann Indian Acad Neurol. 2008 Jan;11(1):20-7
references: 19966974
references: Muscle Nerve. 1986 Nov-Dec;9(9):809-19
references: 3785290
references: N Engl J Med. 1976 Sep 30;295(14):770-2
references: 785257
references: Muscle Nerve. 1989 Aug;12(8):613-26
references: 2550820
references: Ann N Y Acad Sci. 2003 Sep;998:500-8
references: 14592920